Skip to content

Application study on AI-Assisted Techniques and Modality of Individualized Mobile Health Based Smoking Cessation Interventions

Application study on AI-Assisted Techniques and Modality of Individualized Mobile Health Based Smoking Cessation Interventions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112048
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine dependence

Interventions

Intervention group:Use all functions of the AI-assisted Individualized smoking cessation App
Control group:Use limited functions of the AI-assisted Individualized smoking cessation App

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-65 years old 2.Regular smoking for >= 1 year, smoking >=5 cigarettes per day, and currently smoking at the time of enrollment screening 3.Have the intention to quit smoking and plan to quit within one month, hoping to receive smoking cessation assistance 4.Can complete clinic follow-up on time 5.Having a smartphone.

Exclusion criteria

Exclusion criteria: 1.Difficulty understanding the content of the questionnaire 2.Acute exacerbation or requiring hospitalization 3.Have undergone coronary angiography examination or surgical treatment (including but not limited to PCI) in the past month or plan to undergo it within the next month 4.Using smoking cessation meidications or other methods, including nicotine replacement therapy, bupropion, varenicline, electronic cigarettes and other online tools, such as WeChat official account, APPs, etc 5.Participating in other smoking cessation studies or have participated in smoking cessation studies within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Biologically validated 3-month continous abstinence rate;

Secondary

MeasureTime frame
Biologically validated 7-day point prevalence abstinence (PPA) at 1-, 2-, 3-, 6-, 12-month follow-up ;Ssel-reported 7-day point prevalence abstinence (PPA) at 1-, 2-, 3-, 6-, 12-month follow-up ;Seld-reported 1-, 2-, 3-, 6-, 12-month continous abstinence rate;Quit attempt rate;Smoking reduction rate;Usage engagement indicators;Changes in withdrawal symptoms and smoking craving scores at 1- and 3-month follow-ups;

Countries

China

Contacts

Public ContactLiang Lirong

Beijing Chaoyang Hospital, Capital Medical University

llrcruie@163.com+86 134 8872 6198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026